This is a demo store. No orders will be fulfilled.

Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Genetic Technology Alert. Universal Immune Stimulatory Peptide; Site Specific Immunomodulators to Cure Inflammatory Bowel Disease and Cancer; Drug Used to Treat Tumors Targets Cancer Stem Cells

Genetic Technology Alert. Universal Immune Stimulatory Peptide; Site Specific Immunomodulators to Cure Inflammatory Bowel Disease and Cancer; Drug Used to Treat Tumors Targets Cancer Stem Cells

RELEASE DATE
29-May-2015
REGION
Global
Deliverable Type
Technology Alert
Research Code: D756-00-94-00-00
SKU: HC02722-GL-TA_19616
$250.00
In stock
SKU
HC02722-GL-TA_19616
$250.00
DownloadLink
Add to Compare

Pay by invoice

ENQUIRE NOW

Description

This issue profiles an universal immune stimulatory peptide, site specific immunomodulators to cure inflammatory bowel disease and cancer, and a drug that is used to treat tumors can also target cancer stem cells.

Table of Contents

In This Issue

  • 1. UNIVERSAL IMMUNE STIMULATORY PEPTIDE
  • 2. SITE SPECIFIC IMMUNOMODULATORS TO CURE INFLAMMATORY BOWEL DISEASE AND CANCER
  • 3. DRUG USED TO TREAT TUMORS TARGETS CANCER STEM CELLS
  • 4. SOME KEY PATENTS IN IMMUNOMODULATORS
  • 5. TECHVISION 2015
Request Sample
Popular Topics

neurology market

polyamide market

smart lighting market

cyber security market

fleet management market

polypropylene market

glucose monitoring devices market

medical supplies market

industrial robotics market

natural gas market

This issue profiles an universal immune stimulatory peptide, site specific immunomodulators to cure inflammatory bowel disease and cancer, and a drug that is used to treat tumors can also target cancer stem cells.
More Information
Deliverable Types Technology Alert
No Index No
Podcast No
Industries Healthcare
WIP Number D756-00-94-00-00
Is Prebook No
Ti Codes D758